Skip to main content
A Singapore Government Agency Website How to identify
Official website links end with .gov.sg
Government agencies communicate via .gov.sg websites (e.g. go.gov.sg/open). Trusted websites
Secure websites use HTTPS
Look for a lock () or https:// as an added precaution. Share sensitive information only on official, secure websites.

Singapore Translational Cancer Consortium will NEVER ask you to transfer money or disclose bank log-in details over a phone call.

Singapore Translational Cancer Consortium (STCC)

Newsrooms

News, media releases, research highlights, and events from STCC and the global cancer research community

25 articles

5 February 2026

Singapore’s cancer screening gap is widening at a critical moment

Low participation rates, late diagnoses and younger patients point to the urgent need for a rethink. Some recent health statistics paint a troubling picture.

News

Photo of the Healthier SG Programme fair. Photo courtest of LIANHE ZAOBAO.

7 April 2025

National Cancer Centre's Ravindran Kanesvaran on future of cancer care, treatment costs

Measures to strengthen clinical capacity, accelerate innovation in treatment, and ensure more equitable access as Singapore adapts to changing cancer demographics and the growing role of advanced therapies.

News

Photograph of Prof. Ravindran Kanesvaran being interviewed by CNA on the future of cancer care and the rising costs of cancer treatment.

14 March 2025

Professor Ashok Venkitaraman elected as Fellow of prestigious AACR Academy

Professor Ashok Venkitaraman, CSI Singapore Director and STCC Board Oversight Committee member, is elected to the 2025 class of Fellows of the prestigious AACR Academy for his pioneering contributions to cancer research.

News

Photo by American Association for Cancer Research: Prof Ashok Venkitaraman was honoured for his pioneering contributions to cancer research.

1 March 2025

Partnership for advancing cancer research and biobanking in Asia

The National Health Research Institutes (NHRI) in Taiwan and the Singapore Translational Cancer Consortium (STCC) sign an MoU to strengthen cross-border biobanking and translational cancer research.

News

Singapore Translational Cancer Consortium (STCC) site logo

22 January 2025

Discovering a breakthrough in bladder cancer treatment landscape

In a brief conversation with Biospectrum Asia, Dr Kanesvaran, outlined his extensive expertise in tackling Advanced Bladder Cancer (ABC) and its prophylaxis with reference to recent clinical findings.

News

This is a logo of BioSpectrum Asia Edition.

3 January 2025

Advancing Cancer Research & Translation in Singapore – A Look Back at 2024

Highlights from 2024

Articles

Photo of the STCC’s imCORE induction signing ceremony on 24 July 2024.

31 October 2024

Appointment of Associate Professor Ravindran Kanesvaran as Co-Director, STCC from 31 October 2024

Senior leadership appointment change at STCC

News

This is a profile photograph of Associate Professor Ravindran Kanesvaran

29 July 2024

Media Coverage: Singapore patients may get greater access to novel cancer drugs under R&D partnership

STCC named first Southeast Asian member of imCORE — what it means for Singapore.

News

A collage of news articles highlighting how cancer patients in Singapore are gaining improved access to novel treatments and therapies through research partnerships and collaborative initiatives.

24 July 2024

The Singapore Translational Cancer Consortium (STCC) Becomes First Southeast Asian Member of Roche’s imCORE Network of Leading Global Research Centres to Advance Understanding of Cancer Immunotherapy

STCC Becomes First Southeast Asian Member of Roche’s imCORE Network

Media Releases

Photo of the ceremonial signing of the core alliance agreement between STCC and Roche on 24 July 2024. The signing was witnessed by Guest-of-Honour Prof. Tan Chorh Chuan, Permanent Secretary (National Research and Development), Prime Minister’s Office, and Chairman of MOH Office for Healthcare Transformation (MOHT).

30 December 2023

STCC and NCCS collaboration to advance organ on chip platform using Philips technology

STCC and NCCS announce a research collaboration to develop a Philips-enabled Organ-on-Chip platform to scale tumour organoid models and accelerate pre-clinical cancer research in Singapore.

News

Photo of the STCC team with the Philips Technology Licensing team, collaborating on the development and advancement of the Organ-on-Chip (OoC) platform.